| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 274,659 | 271,467 | 268,852 | 327,606 | | Cost of Revenue | 227,475 | 226,264 | 226,369 | 271,285 | | | Gross Profit | 47,184 | 45,203 | 42,483 | 56,321 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 46,066 | 12,905 | 44,092 | 48,992 | | Non Recurring | 486 | 33,360 | (7,930) | (8,853) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 632 | (1,062) | 6,321 | 16,182 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,001 | 3,434 | 1,015 | (3,240) | | Earnings Before Interest And Taxes | 2,633 | 2,372 | 7,336 | 12,942 | | Interest Expense | 15 | 12 | 163 | 614 | | Income Before Tax | 2,618 | 2,360 | 7,173 | 12,328 | | Income Tax Expense | 844 | (488) | 3,059 | 4,146 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,774 | 2,848 | 4,114 | 8,182 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,774 | 2,848 | 4,114 | 8,182 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,774 | $2,848 | $4,114 | $8,182 |
|
0.51% Nasdaq 
Income Statement
